| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 10/01/2002 | CA2281895C Ikb kinases |
| 10/01/2002 | CA2168459C Fusion proteins containing the c-terminal of tetanus toxin linked to a heterologous protein |
| 10/01/2002 | CA2103546C Modified factor vii |
| 10/01/2002 | CA2075209C Virus/herbicide resistance genes process for producing same and their use |
| 10/01/2002 | CA2011304C Expression vectors for the synthesis of proteins in the fission yeast schizosaccharomyces pombe |
| 10/01/2002 | CA1341390C Human protein disulfide isomerase polypeptide and dna encoding the same |
| 09/26/2002 | WO2002075315A1 Method of screening prediabetic state and screening reagent |
| 09/26/2002 | WO2002075045A1 Method for the enzymatic control of pitch deposits formed during paper pulp production using an esterase that hydrolyses triglycerides and sterol esters |
| 09/26/2002 | WO2002074996A1 Gene regulation |
| 09/26/2002 | WO2002074995A1 Method for alteration detection |
| 09/26/2002 | WO2002074993A1 A method for immobilizing molecules with physiological activity |
| 09/26/2002 | WO2002074992A2 Phosphodiesterase 4d genes related to human stroke |
| 09/26/2002 | WO2002074981A2 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase |
| 09/26/2002 | WO2002074979A2 Expression profiles and methods of use |
| 09/26/2002 | WO2002074975A2 Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof |
| 09/26/2002 | WO2002074974A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 09/26/2002 | WO2002074970A1 A process for the production of an inhibitor of human platelet aggregation and soybean lipoxygenase |
| 09/26/2002 | WO2002074966A2 Process for the preparation of l-amino acids by using coryneform bacteria |
| 09/26/2002 | WO2002074965A2 Characterization of the i-spoml endonuclease from fission yeast |
| 09/26/2002 | WO2002074964A2 Polypeptides derived from rna polymerases and use thereof |
| 09/26/2002 | WO2002074960A2 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof |
| 09/26/2002 | WO2002074948A2 Animal tissue with carbohydrate antigens compatible for human transplantation |
| 09/26/2002 | WO2002074945A1 Method for cleaving human growth hormone gh |
| 09/26/2002 | WO2002074944A1 Process for the preparation of l-amino acids by using coryneform bacteria |
| 09/26/2002 | WO2002074943A2 Nucleic acid molecules coding for a dextran-saccharase catalysing the synthesis of dextran with alpha 1,2-osidic sidechains |
| 09/26/2002 | WO2002074942A2 Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics |
| 09/26/2002 | WO2002074935A2 Use of telomerase reverse transcriptase to create homozygous knockout animals |
| 09/26/2002 | WO2002074932A2 Novel human kinase and polynucleotides encoding the same |
| 09/26/2002 | WO2002074928A2 Fusion peptides isolatable by phase transition |
| 09/26/2002 | WO2002074926A2 Myo-inositol oxygenases |
| 09/26/2002 | WO2002074924A2 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof |
| 09/26/2002 | WO2002074913A2 Nucleic acid-associated proteins |
| 09/26/2002 | WO2002074907A2 Methods of modulating surfactant production |
| 09/26/2002 | WO2002074801A1 An osmotic stress-inducible protein functioning as a negative regulator in osmotic stress signaling pathway of plants |
| 09/26/2002 | WO2002074800A1 Gene cluster for rabelomycin biosynthesis and its use to generate compounds for drug screening |
| 09/26/2002 | WO2002074798A2 The genome of a bifidobacterium |
| 09/26/2002 | WO2002074796A2 Histidine phosphatase interacting protein with 240kd |
| 09/26/2002 | WO2002074792A1 Fo-6979 substances and process for producing the same |
| 09/26/2002 | WO2002074788A2 TRP2 ISOFORM TRP2-6b CONTAINING HLA-A2-RESTRICTED EPITOPES |
| 09/26/2002 | WO2002074786A2 Methods of modulating surfactant production |
| 09/26/2002 | WO2002074782A2 Isolation and purification procedure of vasopeptidase peptide inhibitors |
| 09/26/2002 | WO2002074327A2 Compositions and methods for treating gonadotrophin related illnesses |
| 09/26/2002 | WO2002074230A2 A dna molecule encoding a variant paraoxonase and uses thereof |
| 09/26/2002 | WO2002055665A3 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
| 09/26/2002 | WO2002036752A3 Method of producing non-bovine chymosin and use thereof |
| 09/26/2002 | WO2002032461A3 Protein c or activated protein c-like molecules |
| 09/26/2002 | WO2002031155A3 Gene cluster for ramoplanin biosynthesis |
| 09/26/2002 | WO2002029084A3 Industrial-scale serum-free production of recombinant factor vii in mammalian cells |
| 09/26/2002 | WO2002026996A3 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |
| 09/26/2002 | WO2002026954A3 Truncated phosphodiesterase-7 polypeptides |
| 09/26/2002 | WO2002024882A3 Method for glucose production with a modified cellulase mixture |
| 09/26/2002 | WO2002015918A3 Method and compositions for promoting osteogenesis |
| 09/26/2002 | WO2002006442A3 Cell-wall degrading enzyme variants |
| 09/26/2002 | WO2001098332A3 Secreted redox proteins |
| 09/26/2002 | WO2001094600A3 Promoters for regulated gene expression |
| 09/26/2002 | WO2001092488A3 Regulation of human plc delta-1 |
| 09/26/2002 | WO2001092487A3 Modified xylanases exhibiting increased thermophilicity and alkalophilicity |
| 09/26/2002 | WO2001092465A8 Maize glutamine synthetase gene promoter |
| 09/26/2002 | WO2001088109A8 Model for neurodegenerative disease |
| 09/26/2002 | WO2001083775A3 Proteases |
| 09/26/2002 | WO2001061019A3 A dominant selectable marker for gene transformation and disruption in yeasts |
| 09/26/2002 | WO2001032156A3 Methods for treating fibroproliferative diseases |
| 09/26/2002 | WO2001023430A9 Human chitinase immunoglobulin fusion proteins |
| 09/26/2002 | WO2001019385A9 The use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses |
| 09/26/2002 | WO2001018183A9 Methods and compositions for production of floral scent compounds |
| 09/26/2002 | WO2001017533A9 Inhibitor of vascular superoxide anion |
| 09/26/2002 | WO2001011054A9 CRYSTALLIZATION AND STRUCTURE DETERMINATION OF STAPHYLOCOCCUS AUREUS UDP-N-ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE (S. AUREUS MurB) |
| 09/26/2002 | US20020138878 Transgenic plants comprise ligninase and cellulase genes from microbes operably linked to a DNA encoding a signal peptide which targets the fusion polypeptide prodcued therefrom to an organelle of the plant |
| 09/26/2002 | US20020138877 Rad3 orthologues and uses thereof |
| 09/26/2002 | US20020138876 Transformed plant cells and plants regenerated from these cells, which exhibit an increase or reduced activity of starch synthases; genetic engineering |
| 09/26/2002 | US20020138875 Expression of fructose 1,6 bisphosphate aldolase (FDA) in transgenic plants to increase or improve plant growth and development, yield, vigor, stress tolerance, carbon allocation and storage and distribution of starch |
| 09/26/2002 | US20020138874 Elongase genes and uses thereof |
| 09/26/2002 | US20020138870 Methods for simultaneous control of lignin content and composition, and cellulose content in plants |
| 09/26/2002 | US20020138867 Geminivirus resistant transgenic plants |
| 09/26/2002 | US20020138862 Mice show an increased insulin sensitivity, and resistance to weight gain compared to wild-type mice on same diet; screening for enzyme inhibitors; antiobesity, antidiabetic agents |
| 09/26/2002 | US20020138859 Nucleic acid sequences; use of such enzymes to produce taxanes |
| 09/26/2002 | US20020137913 Novel human kinases and polynucleotides encoding the same |
| 09/26/2002 | US20020137910 MN gene and protein |
| 09/26/2002 | US20020137907 Novel compounds |
| 09/26/2002 | US20020137899 Crosslinked through one or more carbohydrate moieties in said glycoprotein; storage stability, chemical stability over wider range of conditions while retaining bioactivity in use |
| 09/26/2002 | US20020137718 Nucleozymes |
| 09/26/2002 | US20020137713 Modulation of cell matrices |
| 09/26/2002 | US20020137712 69109, a novel human tyrosine phosphatase and uses therefor |
| 09/26/2002 | US20020137711 Suppression of hematopoietic enzyme; organ grafting |
| 09/26/2002 | US20020137703 Genetic engineering; insertion vector into polypeptides |
| 09/26/2002 | US20020137700 Nucleic acids; genetic engineering |
| 09/26/2002 | US20020137686 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 09/26/2002 | US20020137678 Treatment of ocular neovascularization and related diseases |
| 09/26/2002 | US20020137673 Factor VII glycoforms |
| 09/26/2002 | US20020137667 Administering a therapeutically effective amount Trypanosoma cruzi trans-sialidase or a neurotrophic variant; amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease, Huntington's disease, Chagas' disease, peripheral neuropathy, |
| 09/26/2002 | US20020137214 Target plants are transformed using a plastid vector which contains heterologous DNA sequences coding for a phytotoxin detoxifying enzyme or protein |
| 09/26/2002 | US20020137190 High growth methanotrophic bacterial strain |
| 09/26/2002 | US20020137185 Enzymes having amidase activity and methods of use thereof |
| 09/26/2002 | US20020137184 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and use thereof |
| 09/26/2002 | US20020137183 Isolated human metalloprotease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 09/26/2002 | US20020137181 14087, a novel serine protease molecule and uses therefor |
| 09/26/2002 | US20020137180 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 09/26/2002 | US20020137179 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 09/26/2002 | US20020137178 Polynucleotide and polypeptide molecules for disintegrin proteases |
| 09/26/2002 | US20020137177 One or more amino acid residues being replaced by cysteine residues where at least some of cysteine residues are modified by replacing thiol hydrogen in cysteine residue with thiol side chain to form modified enzyme |